4//SEC Filing
Edwards Lifesciences Corp 4
Accession 0001225208-17-010120
$EWCIK 0001099800operating
Filed
May 18, 8:00 PM ET
Accepted
May 19, 4:25 PM ET
Size
15.9 KB
Accession
0001225208-17-010120
Insider Transaction Report
Form 4
Verguet Patrick B
CVP, Europe
Transactions
- Exercise/Conversion
Common Stock
2017-05-17$44.62/sh+8,000$356,920→ 141,768.15 total - Sale
Common Stock
2017-05-17$113.21/sh−4,631$524,272→ 137,137.15 total - Sale
Common Stock
2017-05-17$113.15/sh−8,000$905,221→ 129,137.15 total - Exercise/Conversion
Common Stock
2017-05-19$44.62/sh+10,000$446,150→ 139,137.15 total - Sale
Common Stock
2017-05-19$113.13/sh−10,000$1,131,346→ 129,137.15 total - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2017-05-17−8,000→ 58,800 totalExercise: $44.62From: 2012-05-12Exp: 2018-05-11→ Common Stock (8,000 underlying) - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2017-05-19−10,000→ 48,800 totalExercise: $44.62From: 2012-05-12Exp: 2018-05-11→ Common Stock (10,000 underlying)
Footnotes (4)
- [F1]This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
- [F2]This transaction was executed in multiple trades at prices ranging from $113.2091 to $113.2150. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $113.1340 to $113.1550. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $113.00 to $113.21. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Edwards Lifesciences Corp
CIK 0001099800
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001099800
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 4:25 PM ET
- Size
- 15.9 KB